Approximately every nine minutes, someone in the United States dies from a blood cancer, according to the Leukemia & Lymphoma ...

This is called overall response rate (ORR). Researchers also looked at how long the people in the study lived without their cancer worsening. This is called progression-free survival (PFS).

Jennifer Flowers thought her pain and fatigue were a side effect of working out. Perhaps she’d pushed herself too hard or strained a muscle. But the pain persisted, so she scheduled an ...

Multiple myeloma is a type of cancer where plasma cells in bone marrow ... or kidney failure wasn’t associated with a worsened survival rate. Researchers concluded that the development of ...

The cancer, which forms a tumor or tumors ... That said, the five-year relative survival rate of myeloma patients diagnosed ...

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

Median duration of response (DOR), progression-free survival ... Cancer Research annual meeting. "Linvoseltamab demonstrated high efficacy in patients with relapsed/refractory multiple myeloma ...

This covers cancers such as non-Hodgkin lymphoma, leukaemia, and multiple myeloma ... in survival are reflected in reductions in mortality. Compared to a peak in blood cancer death rates in ...

Multiple myeloma is a type of blood cancer that affects plasma cells ... advancements in medical care have significantly improved survival rates in recent years. The five-year survival rate ...

If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone ... bone marrow transplant at MSK had a much higher predicted rate of 1-year survival. MSK ...